What is a Bariatric Surgery?
It is a procedures cause weight loss by restricting the amount of food the stomach can hold, causing malabsorption of nutrients, or by a combination of both gastric restriction and malabsorption.
Bariatric procedures also often cause hormonal changes. Most weight loss surgeries today are performed using minimally invasive techniques (laparoscopic surgery).
The most common bariatric surgery procedures are gastric bypass, sleeve gastrectomy, adjustable gastric band, and biliopancreatic diversion with duodenal switch. Each surgery has its own advantages and disadvantages.
Bariatric Surgery Devices Market is anticipated to reach 2.8 billion by 2022. It is anticipated to grow at a healthy rate in the years to come. Bariatric surgery is mostly used to decrease body weight. Bariatric surgery implies the treatment of comorbid condition, which is related with morbid fatness. Obesity is one of the utmost threatening and prevalent health disorders has increased alertness about bariatric devices and surgery.
The demand for bariatric surgery devices has witnessed a substantial rise due to advantages such as rising preference for less-invasive bariatric operations. In addition, the increasing spending on weight loss actions has helped the sales of bariatric surgery devices at the distinct level. Regional government enterprises are also prompting the development of the bariatric surgery devices market.
On the other hand, the factors that may hamper the growth of the Bariatric Surgery Devices Market include high cost of surgeries, lower disposable income developing economies, lack of awareness in the emerging countries. The market is anticipated to grow at the significant CAGR of 10.15% in the upcoming period as the scope, product types, and its applications are increasing across the globe.
Request Sample Copy of This Market Research @
The market may be explored by procedure, type, end users, and geography. It may be explored by type as Energy/Vessel Sealing Devices, Minimally Invasive Surgical Devices, Stapling Devices, Suturing Devices, Non-invasive Surgical Accessories, and Devices. In 2018 the largest market share was dominated by “minimally invasive surgical devices” in the global Market. The facts that attribute to the huge development in this segment can be ascribed to the growing obesity rates and the growing preference for nominally invasive procedures.
Bariatric Surgery Devices Market may be explored by procedure as Gastric Bypass, Biliopancreatic Diversion with Duodenal Switch, Revision Bariatric Surgery Adjustable Gastric Banding, Sleeve Gastrectomy, Non-invasive Bariatric Surgery, and Mini-gastric Bypass. The “sleeve gastrectomy” section dominated the blood screening market in 2017 and is anticipated to maintain its dominance by 2022 due to facts such as advantages of effectiveness, affordability, and sleeve gastrectomy protection, and partial complications as associated to other bariatric methods.
Bariatric Surgery Devices Market may be explored by end users as surgical centers, hospital & clinics, and others. North America accounted for the major share of the global Market Size Analysis in 2016 and will continue to lead in the forecast period due to factors such as increase in the several bariatric surgeries and constantly increasing obese population, increase government supported research and funding activities undertaken by the manufacturing companies in North America region, followed by Europe.
Browse Full Research Report @
Some of the key players that fuel the growth of the Bariatric Surgery Devices Industry comprise Medtronic, Ethicon, Intuitive Surgical, Cousin Biotech, Apollo Endo-surgery, Reshape Lifesciences, Olympus Corporation of the Americas, Aspire Bariatrics, Mediflex Surgical Products, Spatz Fgia. The leading companies are taking up partnerships, mergers and acquisitions, and joint ventures in order to boost the inorganic growth of the industry.
Procedure Outlook (Revenue, USD Million, 2012 – 2022)
• Adjustable Gastric Band (AGB)
• Vertical Sleeve Gastrectomy (VSG)
• Roux-en-Y Gastric Bypass (RYGB)
• Biliopancreatic Diversion with a Duodenal Switch (BPD-DS)